PCSK9 Forum
8th April 2015
Facebook Twitter RSS YouTube
For latest updates
Register today
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
EAS 2015

News from the European Atherosclerosis Society Congress 2015

New EAS Consensus Statement

Side-effect and consequent non-adherence limit statin efficacy in practice

Muscle symptoms often result in poor adherence or treatment discontinuation in statin treated patients. Consequently the efficacy of these valuable therapies is compromised and, as a result, cardiovascular mortality in these patients may be increased by nearly 50%.

Responding to this critically important clinical issue, a Consensus Panel of The European Atherosclerosis Society (EAS) has issued a statement addressing these key questions:

Send an invitation to join PCSK9 Forum to your colleagues »
PCSK9 Education and Research Forum

Invotation from John Chapman
Aims & Objectives video
Read our Mission Statement
Partnership and outreach
Meet our Editorial Board
View Forthcoming Meetings
  Follow us on Twitter
For the latest updates on the hot topics, PCSK9 news and conference reports.
Latest Videos

Familial hypercholesterolaemia: putting the patient first
Katherine Wilemon

European Atherosclerosis Society Consensus Panel on statin-associated muscle symptoms
Erik Stroes

What are the current unmet needs?
Erik Stroes

Why is it critical to target children with FH?
Albert Wiegman

View our YouTube channel »
See more on pcsk9forum.org
Send to a colleague »

Coming soon reports from:
ISA 2015 17th International Symposium on Atherosclerosclerosis
23 May 2015, Amsterdam, the Netherlands
  Supported by educational grants from: Amgen Lilly pFizer Sanofi  
Copyright PCSK9 Forum 2015. Please click here to unsubscribe from future mailings.